ARCHIVES

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

This article is from The Cancer Letter archive.

Vol. 25 No. 47 | December 10, 1999

Download PDF Visit The Full Archive

Related Articles

DCE Board Ok’s New RFA Programs worth $14 Million

June 29, 1990

Sarcoma, Li-Fraumeni Linked; Genetic Counseling Recommended

February 24, 2012

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

September 9, 2011

Obey Again – Now He’s Blasting NCI For Not Helping NIOSH

September 17, 1976

Tissue Bank Visibility Could Be Improved By Centralized Listing Of Resources: Panel

September 30, 1994